Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

October 31, 2027

Conditions
Acute-on-Chronic Liver Failure (ACLF)
Interventions
DRUG

Vitamin C

Intravenous Vitamin C, 25 mg/kg (maximum 1.5 g) every 6 hours for 5 days, administered in addition to standard medical treatment

OTHER

Standard of Care (SOC)

Supportive and guideline-based management of ACLF with septic shock and AKI, including antibiotics, fluids, vasopressors, renal replacement therapy as required, and other standard therapies

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT07184866 - Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter